DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: diabetes treatment

News

Sanofi and MannKind Enter Global Licensing Agreement for Afrezza Insulin

13.08.2014 - Sanofi and MannKind Corporation have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a...

News

Novo Nordisk Launches Diabetes Drug in Germany After Rethink

02.06.2014 - Danish drugmaker Novo Nordisk, the world's biggest insulin producer, has decided to launch its diabetes drug Tresiba in Germany after seeing signs of a more favorable pricing...

News

U.S. Court Fines Takeda, Lilly $9 billion Over Diabetes Drug Safety

09.04.2014 - Japanese drug giant Takeda Pharmaceutical has vowed to fight a $6 billion damages award to U.S. plaintiffs who blamed its Actos diabetes drug for their bladder cancer. The company...

News

Bayer to Spend €100 Million on Chinese Pharma Packaging Upgrade

31.03.2014 - Bayer HealthCare plans to spend around €100 million to "significantly increase" capacity of its Beijing, China pharmaceutical packaging facilities, the Leverkusen-based group said...

News

Novo Nordisk Sees Chance of U.S. Tresiba Launch Before Rivals

21.03.2014 - Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...

News

Gene Mutations for Type 2 Diabetes Discovered

04.03.2014 - Scientists have uncovered gene mutations that slash the risk of Type 2 diabetes regardless of age and weight, offering drugmakers a novel target to combat one of the major health...

News

Roche Decides Against Selling Diabetes Device Unit

20.09.2013 - Swiss drugmaker Roche has decided against trying to sell its blood glucose meter business, according to two people familiar with the matter. In the past few months, Roche was...

News

Sanofi Steps up Diabetes Drive as Rivals Raise the Stakes

07.06.2013 - In a leafy suburb of Frankfurt, a state-of-the-art plant churns out up to 1 million insulin pens every day in French drugmaker Sanofi's drive to keep its no. 2 spot in the $43...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!